Moderna shares surged 57% and Merck gained over 6% after the companies announced positive results from a personalized cancer vaccine in a late-stage trial. Keysight Technologies rose 2% following quarterly results that exceeded expectations, posting earnings of $3.07 per share and revenue of $1.85 billion. La-Z-Boy dropped nearly 17% due to a 9% decline in earnings and revenue guidance that missed consensus estimates. Estee Lauder gained over 7% after beating earnings and revenue estimates for the fiscal fourth quarter.
Source: Read the original article
